Masimo announced U.S. Food and Drug Administration 510(k) clearance for the Root patient monitoring and connectivity platform. The platform includes a built-in connectivity gateway through Iris for ...

LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) ...

In 2013, Masimo introduced the Root ® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and ...

Masimo Corporation MASI recently received the CE mark, under the European Union Medical Device Regulation (EU MDR), for the LiDCO board-in-cable (BIC) module. However, the parameter as a measure of ...

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...

Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...